VASCULITIS SYNDROMES RAVE about rituximab in ANCA vasculitis?

被引：1

作者：

Tarzi, Ruth ^{[1
]}

Pusey, Charles ^{[1
]}

机构：

[1] Hammersmith Hosp, Dept Med, Renal & Vasc Inflammat Sect, London W12 0NN, England

来源：

NATURE REVIEWS NEPHROLOGY | 2013年 / 9卷 / 11期

关键词：

ANTIBODY-ASSOCIATED VASCULITIS; WEGENERS-GRANULOMATOSIS; CYCLOPHOSPHAMIDE; REMISSION; INDUCTION; EFFICACY; THERAPY;

D O I：

10.1038/nrneph.2013.204

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Follow-up data from the RAVE trial have shown that rituximab is as effective as immunosuppression with cyclophosphamide followed by azathioprine in antineutrophil cytoplasmic antibody (ANCA) associated vasculitis. Rituximab is likely to become the standard of care for many patients with ANCA disease. However, an individualized approach is needed to identify those who require more-intense or prolonged therapy.

引用

页码：628 / 629

页数：2

共 50 条

[21] Rituximab for ANCA-associated vasculitis in the setting of severe infection
Gregersen, J. W.
Chaudhry, A.
Jayne, D. R. W.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2013, 42 (03) : 207 - 210
[22] Case report: de novo ANCA-associated vasculitis after kidney transplantation treated with rituximab and plasma exchange
Sagmeister, Michael S.
Weiss, Max
Eichhorn, Peter
Habicht, Antje
Habersetzer, Rupert
Fischereder, Michael
Schoenermarck, Ulf
BMC NEPHROLOGY, 2018, 19
[23] Evidence-based management of ANCA vasculitis
Carruthers, David
Sherlock, Jonathan
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2009, 23 (03): : 367 - 378
[24] Advances in Therapy for ANCA-Associated Vasculitis
Geetha, Duvuru
Seo, Philip
CURRENT RHEUMATOLOGY REPORTS, 2012, 14 (06) : 509 - 515
[25] Recommendations on the use of rituximab for ANCA-associated vasculitis
Gause, A. M.
Rubbert-Roth, A.
ZEITSCHRIFT FUR RHEUMATOLOGIE, 2014, 73 (03): : 287 - 289
[26] The Search for a Biomarker of Relapse in ANCA-Associated Vasculitis
Free, Meghan E.
Falk, Ronald J.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (09): : 2551 - 2553
[27] Treatment of ANCA-Associated Vasculitis, Where to Go?
Kallenberg, Cees G. M.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2012, 43 (03) : 242 - 248
[28] Advances in the maintenance of ANCA vasculitis remission
Guillevin, Loic
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2023, 37 (01):
[29] Impact of rituximab trials on the treatment of ANCA-associated vasculitis
Alberici, Federico
Jayne, David R. W.
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (06) : 1151 - 1159
[30] Rituximab for treatment of severe renal disease in ANCA associated vasculitis
Geetha, Duvuru
Hruskova, Zdenka
Segelmark, Marten
Hogan, Jonathan
Morgan, Matthew D.
Cavero, Teresa
Eriksson, Per
Seo, Philip
Manno, Rebecca L.
Dale, Jessica
Harper, Lorraine
Tesar, Vladimir
Jayne, David R. W.
JOURNAL OF NEPHROLOGY, 2016, 29 (02) : 195 - 201

← 1 2 3 4 5 →